Characteristics | Patients (N = 132) | Purpose of CV-port implantation | p-value | |
CC group (N = 79) | PC group (N = 53) | |||
Sex, N (%) |
|
|
|
|
Male | 90 | 53 (58.9) | 37 (41.1) |
|
Female | 42 | 26 (61.9) | 16 (38.1) | 0.849 |
Age (years) |
|
|
|
|
Median (range) | 67 (36 - 87) | 66 (36 - 85) | 67.5 (42 - 87) | 0.232 |
Histology, N (%) |
|
|
|
|
SCLC | 35 | 27 (77.1) | 8 (22.9) |
|
NSCLC | 97 | 52 (53.6) | 45 (46.4) | 0.016 |
ECOG PS, N (%) |
|
|
|
|
0 - 1 | 59 | 58 (98.3) | 1 (1.7) |
|
2 - 3 | 51 | 20 (39.2) | 31 (60.8) |
|
4 | 22 | 1 (4.5) | 21 (95.5) | <0.0001 |
Stage, N (%) |
|
|
|
|
I-II | 5 | 4 (80.0) | 1 (20.0) |
|
IIIA-B | 14 | 11 (78.6) | 3 (21.4) |
|
IV | 113 | 64 (56.6) | 49 (43.4) | 0.243 |
Insertion site of the CV-port, N (%) |
|
|
|
|
RSV | 91 | 60 (65.9) | 31 (34.1) |
|
LSV | 23 | 13 (56.5) | 10 (43.5) |
|
RIV | 16 | 5 (31.3) | 11 (68.7) |
|
LIV | 1 | 0 (0.0) | 1 (100.0) |
|
RIJV | 1 | 1 (100.0) | 0 (0.0) |
|
Preimplantation chemotherapy |
|
|
|
|
Number of regimens, median (range) | 2 (0 - 7) | 2 (0 - 7) | 2 (0 - 6) | 0.060 |
Number of cycles, median (range) | 5 (0 - 65) | 8 (0 - 65) | 4 (0 - 25) | 0.006 |